Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Santuccio

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancers|February 24, 2024
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin LymphomaAndrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Frontiers in Cellular and Infection Microbiology|January 1, 2026
Clinical, genomic, and functional characterization of vancomycin-resistant <i>Enterococci</i> from immunocompromised patients: insights into epithelial dysfunction and bloodstream infectionsGiuseppe Sangiorgio, Ilenia Martina Pia Filannino, Giuseppe Migliorisi, et al.
Journal of Clinical Medicine|January 8, 2025
Emergencies in Hematology: Why, When and How I Treat?Andrea Duminuco, Vittorio Del Fabro, Paola De Luca, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic LandscapeAndrea Duminuco, Patrick Harrington, Vittorio Del Fabro, et al.
Annals of Hematology|April 17, 2024
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life surveyAndrea Duminuco, Alessandra Romano, Isacco Ferrarini, et al.
European Journal of Haematology|November 24, 2025
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life StudyAndrea Duminuco, Vittorio Del Fabro, Gabriella Santuccio, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2025
Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real-Life Case Series and Literature ReviewGaetano Giuffrida, Uros Markovic, Stephanie Grasso, et al.
Frontiers in Pharmacology|June 1, 2026
The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort studyUros Markovic, Gabriele Sapuppo, Sara Frazzetto, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancers|February 24, 2024
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin LymphomaAndrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Frontiers in Cellular and Infection Microbiology|January 1, 2026
Clinical, genomic, and functional characterization of vancomycin-resistant <i>Enterococci</i> from immunocompromised patients: insights into epithelial dysfunction and bloodstream infectionsGiuseppe Sangiorgio, Ilenia Martina Pia Filannino, Giuseppe Migliorisi, et al.
Journal of Clinical Medicine|January 8, 2025
Emergencies in Hematology: Why, When and How I Treat?Andrea Duminuco, Vittorio Del Fabro, Paola De Luca, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic LandscapeAndrea Duminuco, Patrick Harrington, Vittorio Del Fabro, et al.
Annals of Hematology|April 17, 2024
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life surveyAndrea Duminuco, Alessandra Romano, Isacco Ferrarini, et al.
European Journal of Haematology|November 24, 2025
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life StudyAndrea Duminuco, Vittorio Del Fabro, Gabriella Santuccio, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2025
Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real-Life Case Series and Literature ReviewGaetano Giuffrida, Uros Markovic, Stephanie Grasso, et al.
Frontiers in Pharmacology|June 1, 2026
The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort studyUros Markovic, Gabriele Sapuppo, Sara Frazzetto, et al.
Pageof 1